<DOC>
	<DOC>NCT02877615</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of S 44819 in enhancing functional recovery after an ischemic stroke.</brief_summary>
	<brief_title>Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria : Patients aged between 18 and 80 years (both inclusive) Acute ischemic stroke that occured at least 72 hours (3 days) and less than 144 hours (6 days) (both inclusive) before inclusion Exclusion criteria : Any nonselection criteria, which could have occurred after the selection visit Positive urinary or blood pregnancy test (for female patients of child bearing potential) Any clinically findings from the local laboratory test likely to interfere with the ability to participate in the study and / or with the study outcome Severe renal impairment detected in the local laboratory test Severe hepatic impairment or liver enzymes abnormalities found in the local laboratory test Stroke due to cerebral venous thrombosis Brain MRI showing a severe microangiopathy Brain MRI showing an acute lesion in brain stem or cerebellum Brain imaging showing an acute haemorrhagic stroke or a symptomatic haemorrhagic transformation of the brain infarct Qualifying ischemic cerebral event older than 144 hours at inclusion Any clinically relevant abnormalities detected during the examinations likely to interfere with study procedures or study outcome, Repeated prolongation of ECG QTcF Patient or authorised representative refusing to attend study visits or to take part in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>